Aprimo adds OpenAI ChatGPT integration to its content operations platform
Embedded AI assistant will enable teams to efficiently scale transformative customer experiences CHICAGO–(BUSINESS WIRE)–Aprimo, an…
News
Employee Experience and Reskilling Investments Rise Amid Disruption
48% of respondents are prioritizing integration of modern technologies into existing processes to support a…
New Responsible Artificial Intelligence (RAI) Course for K-12 Educators Seeks to Change How AI is Implemented in Learning
The RAI for Educators Course by MindSpark Will Equip the Education Sector with the Knowledge…
SEMIFIVE Achieves Mass Production Milestone of its SoC Platform
The first customer AI inference chip based on its SoC Platform enters volume production SAN…
Verizon is your home for awesome. Introducing the new Samsung Galaxy A54 5G
Awesome phone. Awesome network. Awesome buy. BASKING RIDGE, N.J., April 04, 2023 (GLOBE NEWSWIRE) —…
Syncfusion Releases Essential Studio 2023 Volume 1
Release delivers new .NET MAUI controls, more production-ready web components, and enhanced accessibility in file-format…
John Snow Labs Puts Responsible AI to Practice with the Release of the NLP Test Library
The New Open-Source Python Library Enables Data Scientists to Automatically Generate & Run Tests and…
SmartDreams Brings Magic to Story Time as the First Children’s App to Use Generative AI to Enable Kids Ages 3+ to Create & Illustrate Their Very Own Bedtime Stories
Husband & Wife Entrepreneurs, Nick Desai and Dr. Renee Dua, Inspired by their Own Children…
Workrise Hires Ed Neumann as Chief Financial Officer and Promotes Joshua Trott to Chief Revenue Officer to Advance Strategic Growth
AUSTIN, Texas–(BUSINESS WIRE)–Workrise, the leading workforce and vendor management platform serving the energy sector, has…
TNS Deploys Cloud Compute Servers and Network Hardware for Coinbase Derivatives Exchange
Connectivity Bolsters Crypto Trading with TNS Network Access and Stability RESTON, Va.–(BUSINESS WIRE)–Transaction Network Services…
Pantheon Announces Best in WebOps Top 20
Award winners are recognized for achieving exceptional web impact SAN FRANCISCO–(BUSINESS WIRE)–#BestInWebOps—Pantheon, the SaaS-based website…
Dot Compliance Launches First AI-Based ChatGPT Powered eQMS For Life Sciences
Primed to revolutionize quality management and compliance for the life sciences industry, Dot Compliance’s ready-to-use…
Vallon Pharmaceuticals Provides an Update on Proxy Voting for the Proposed Merger with GRI Bio and Urges Stockholders of Record as of March 6, 2023 to Vote by April 11, 2023, at 11:59 PM ET
Over 90% of the shares voted to date have shown support “FOR” each of the…
Vallon Pharmaceuticals Provides an Update on Proxy Voting for the Proposed Merger with GRI Bio and Urges Stockholders of Record as of March 6, 2023 to Vote by April 11, 2023, at 11:59 PM ET
Over 90% of the shares voted to date have shown support “FOR” each of the…
Celularity Announces Acceptance of Poster Presentation at 2023 Society for Biomaterials Annual Meeting
FLORHAM PARK, N.J., April 04, 2023 (GLOBE NEWSWIRE) — Celularity Inc. (Nasdaq: CELU) (“Celularity”), a…
Clearmind Medicine Announces Pricing of US$3.5 Million Public Offering
Tel Aviv, Israel / Vancouver, Canada, April 04, 2023 (GLOBE NEWSWIRE) — Clearmind Medicine Inc….
Celularity Announces Acceptance of Poster Presentation at 2023 Society for Biomaterials Annual Meeting
FLORHAM PARK, N.J., April 04, 2023 (GLOBE NEWSWIRE) — Celularity Inc. (Nasdaq: CELU) (“Celularity”), a…
Clearmind Medicine Announces Pricing of US$3.5 Million Public Offering
Tel Aviv, Israel / Vancouver, Canada, April 04, 2023 (GLOBE NEWSWIRE) — Clearmind Medicine Inc….
AIM ImmunoTech Announces Central IRB Approval of Phase 2 Study Protocol Evaluating Ampligen® for the Treatment of Post-COVID Conditions
Preliminary data of Ampligen seen to date demonstrates potential to be an effective treatment option…
AIM ImmunoTech Announces Central IRB Approval of Phase 2 Study Protocol Evaluating Ampligen® for the Treatment of Post-COVID Conditions
Preliminary data of Ampligen seen to date demonstrates potential to be an effective treatment option…